- Home
- Publications
- Publication Search
- Publication Details
Title
T‐Cell‐Mimicking Nanoparticles for Cancer Immunotherapy
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume 32, Issue 39, Pages 2003368
Publisher
Wiley
Online
2020-08-28
DOI
10.1002/adma.202003368
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T cell receptor-engineered T cells for leukemia immunotherapy
- (2019) Yikai Zhang et al. Cancer Cell International
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy
- (2019) Yutong Han et al. Advanced Science
- Engineering nanoparticles to locally activate T cells in the tumor microenvironment
- (2019) Dangge Wang et al. Science Immunology
- Cell Membrane Coating Nanotechnology
- (2018) Ronnie H. Fang et al. ADVANCED MATERIALS
- PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
- (2018) Xudong Zhang et al. ADVANCED MATERIALS
- Adoptive T cell therapy: points to consider
- (2018) Cassian Yee CURRENT OPINION IN IMMUNOLOGY
- Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics
- (2018) Rajendran JC Bose et al. DRUG DISCOVERY TODAY
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy
- (2018) Yukun Huang et al. Acta Pharmaceutica Sinica B
- T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity
- (2018) Xiaoli Wei et al. ADVANCED MATERIALS
- PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy
- (2018) Lukasz J. Ochyl et al. BIOMATERIALS
- Engineering PD-1-Presenting Platelets for Cancer Immunotherapy
- (2018) Xudong Zhang et al. NANO LETTERS
- Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis
- (2018) Qiangzhe Zhang et al. Nature Nanotechnology
- FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells
- (2018) Xiangbo Meng et al. NATURE
- Adoptive T Cell Therapy: New Avenues Leading to Safe Targets and Powerful Allies
- (2018) Dora Hammerl et al. TRENDS IN IMMUNOLOGY
- Transforming of the Tumor Microenvironment: Implications for TGF-β Inhibition in the Context of Immune-Checkpoint Therapy
- (2018) Stefanie Löffek Journal of Oncology
- Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer
- (2017) Lianru Zhang et al. International Journal of Nanomedicine
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- Role of LFA-1 and ICAM-1 in Cancer
- (2017) Manuel Reina et al. Cancers
- Anti-Fas Antibody Conjugated Nanoparticles Enhancing the Antitumor Effect of Camptothecin by Activating the Fas–FasL Apoptotic Pathway
- (2016) Hongliang Yu et al. ACS Applied Materials & Interfaces
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Biomimetic proteolipid vesicles for targeting inflamed tissues
- (2016) R. Molinaro et al. NATURE MATERIALS
- Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
- (2016) R. Palomba et al. Scientific Reports
- Anticancer Platelet-Mimicking Nanovehicles
- (2015) Quanyin Hu et al. ADVANCED MATERIALS
- The role of CD95 and CD95 ligand in cancer
- (2015) M E Peter et al. CELL DEATH AND DIFFERENTIATION
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study
- (2015) Bei Yang et al. JOURNAL OF MOLECULAR MODELING
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- T-cell exhaustion in the tumor microenvironment
- (2015) Y Jiang et al. Cell Death & Disease
- PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
- (2015) Nikolaos Patsoukis et al. Nature Communications
- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKCα–p38–SP-1 pathway
- (2014) Pu Zhang et al. FASEB JOURNAL
- NFATc1 Regulates PD-1 Expression upon T Cell Activation
- (2014) K. J. Oestreich et al. JOURNAL OF IMMUNOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Dacarbazine in Melanoma: From a Chemotherapeutic Drug to an Immunomodulating Agent
- (2013) Selma Ugurel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
- (2012) R. J. deLeeuw et al. CLINICAL CANCER RESEARCH
- Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
- (2012) Alice Hervieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions
- (2012) Alessandro Parodi et al. Nature Nanotechnology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers
- (2011) Forrest M. Kievit et al. ADVANCED MATERIALS
- Cell-Intrinsic Transforming Growth Factor-β Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence In Vivo
- (2009) Roberto Tinoco et al. IMMUNITY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now